More importantly, we demonstrated that MITF regulates tumor progression in ccRCC cell via the RhoA/YAP signaling pathway; taken together, the results suggest that MITF could be a potential therapeutic target in ccRCC. This evidence concerns the gene MITF and nonpapillary renal cell carcinoma.